Pathology of inhalation anthrax in cynomolgus monkeys (Macaca fascicularis)
- PMID: 12920249
- DOI: 10.1097/01.lab.0000080599.43791.01
Pathology of inhalation anthrax in cynomolgus monkeys (Macaca fascicularis)
Abstract
Anthrax is considered a serious biowarfare and bioterrorism threat because of its high lethality, especially by the inhalation route. Rhesus macaques (Macaca mulatta) are the most commonly used nonhuman primate model of human inhalation anthrax exposure. The nonavailability of rhesus macaques necessitated development of an alternate model for vaccine testing and immunologic studies. This report describes the median lethal dose (LD(50)) and pathology of inhalation anthrax in cynomolgus macaques (Macaca fascicularis). Gross and microscopic tissue changes were reviewed in 14 cynomolgus monkeys that died or were killed after aerosol exposure of spores of Bacillus anthracis (Ames strain). The LD(50) and 95% confidence intervals were 61800 (34000 to 110000) colony-forming units. The most common gross lesions were mild splenomegaly, lymph node enlargement, and hemorrhages in various organs, particularly involving the meninges and the lungs. Mediastinitis, manifested as hemorrhage or edema, affected 29% of the monkeys. Microscopically, lymphocytolysis occurred in the intrathoracic lymph nodes and spleens of all animals, and was particularly severe in the spleen and in germinal centers of lymph nodes. Hemorrhages were common in lungs, bronchial lymph nodes, meninges, gastrointestinal tract, and mediastinum. These results demonstrate that the Ames strain of B. anthracis is lethal by the inhalation route in the cynomolgus macaque. The LD(50) of the Ames strain of B. anthracis was within the expected experimental range of previously reported values in the rhesus monkey in an aerosol challenge. The gross and microscopic pathology of inhalation anthrax in the cynomolgus monkey is remarkably similar to that reported in rhesus monkeys and humans. The results of this study are important for the establishment of an alternative nonhuman primate model for evaluation of medical countermeasures against inhalational anthrax.
Similar articles
-
Pathology of inhalational anthrax infection in the african green monkey.Vet Pathol. 2007 Sep;44(5):716-21. doi: 10.1354/vp.44-5-716. Vet Pathol. 2007. PMID: 17846250
-
Pathology of experimental inhalation anthrax in the rhesus monkey.Lab Invest. 1995 Nov;73(5):691-702. Lab Invest. 1995. PMID: 7474943
-
The pathology of experimental anthrax in rabbits exposed by inhalation and subcutaneous inoculation.Arch Pathol Lab Med. 1998 Nov;122(11):982-92. Arch Pathol Lab Med. 1998. PMID: 9822127
-
Pathology of inhalational anthrax animal models.Vet Pathol. 2010 Sep;47(5):819-30. doi: 10.1177/0300985810378112. Epub 2010 Jul 23. Vet Pathol. 2010. PMID: 20656900 Review.
-
[Inhalation anthrax].Ugeskr Laeger. 2000 Sep 4;162(36):4786-9. Ugeskr Laeger. 2000. PMID: 10994373 Review. Danish.
Cited by
-
Efficacy of ETI-204 monoclonal antibody as an adjunct therapy in a New Zealand white rabbit partial survival model for inhalational anthrax.Antimicrob Agents Chemother. 2015 Apr;59(4):2206-14. doi: 10.1128/AAC.04593-14. Epub 2015 Feb 2. Antimicrob Agents Chemother. 2015. PMID: 25645849 Free PMC article.
-
Effective antiprotease-antibiotic treatment of experimental anthrax.BMC Infect Dis. 2005 Apr 8;5:25. doi: 10.1186/1471-2334-5-25. BMC Infect Dis. 2005. PMID: 15819985 Free PMC article.
-
Human lung innate immune response to Bacillus anthracis spore infection.Infect Immun. 2007 Aug;75(8):3729-38. doi: 10.1128/IAI.00046-07. Epub 2007 May 21. Infect Immun. 2007. PMID: 17517878 Free PMC article.
-
Clinical and Translational Pharmacology Considerations for Anti-infectives Approved Under the FDA Animal Rule.Clin Pharmacokinet. 2023 Jul;62(7):943-953. doi: 10.1007/s40262-023-01267-x. Epub 2023 Jun 16. Clin Pharmacokinet. 2023. PMID: 37326917 Free PMC article. Review.
-
Modeling Rabbit Responses to Single and Multiple Aerosol Exposures of Bacillus anthracis Spores.Risk Anal. 2017 May;37(5):943-957. doi: 10.1111/risa.12688. Epub 2017 Jan 25. Risk Anal. 2017. PMID: 28121020 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials